A detailed history of Versant Venture Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,646,657 shares of RPTX stock, worth $3.57 Million. This represents 23.86% of its overall portfolio holdings.

Number of Shares
2,646,657
Previous 2,646,657 -0.0%
Holding current value
$3.57 Million
Previous $8.73 Million 4.25%
% of portfolio
23.86%
Previous 19.39%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$8.63 - $12.53 $22.8 Million - $33.2 Million
2,646,657 New
2,646,657 $28 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.